Today, COVID-19 is defining our lives. The coronavirus disease outbreak has caught us by surprise resulting in many causalities and economic damage. As of today, more than 1,4 million coronavirus cases have occurred in approx. 200 countries. More than 82 thousand patients have died as a result of this viral infection. Undoubtedly, COVID-19 will change […]
Victor Schut has been appointed as the new Chief Executive Officer (CEO) of AGILeBiotics and co-founder Dr. Andreas A. Bastian has now taken on the role of Chief Operating Officer (COO). Currently raising Series A investment, the appointments come in line with the company’s plans and development strategy.
AGILeBiotics B.V. is a pharmaceutical company focusing on the development of novel antibiotics for the treatment of multi-drug resistant infections
